Fit and active at 60, Maggie didn’t think she could have a heart attack. But that all changed one day. Now Maggie is determined to stop heart disease from taking the life she loves – and the things she loves doing.
This trial was looking at the use of Evolocumab, a new class of lipid lowering medication (PCSK9 inhibitors). It is an injectable monoclonal antibody that increases LDL receptor numbers on liver cells taking LDL out of the circulation, lowering it by 60%.
New research has been released on the benefits of eating 10 serves of fruit and veges every day. Our nutrition experts share their real-life experience of the 10+ a day challenge and we share our five top tips to get 10+ a day into your day.